Mechanisms of fever induced by recombinant human interferon.
Since the early trials using human interferon (hIFN) derived from blood leukocytes or cell lines, fever has been a prominent component of IFN therapy. Human protein impurities might account for the fever to cell-derived hIFN, but recombinant hIFN, free of extraneous human proteins, has produced feve...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1984
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425246/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6590569/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111508 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
